Digitalis purpurea
Digitalis purpurea · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Digitalis purpurea is a plant species renowned for its significant pharmacological properties, particularly due to the presence of potent cardiac glycosides like digitoxin. Found primarily in the leaves and seeds, these chemical compounds serve as vital components in treating serious medical conditions such as atrial fibrillation and cardiac failure. Research into various preparations, including CH2Cl2-MeOH (1:1) extracts and infusions of digitalis, has highlighted its diverse biological activities. Beyond its cardiovascular applications, the plant exhibits roles as an 11B-HSD-inhibitor, an ACE-inhibitor, and even an acaricide. Understanding the complex chemical profile of this species remains essential for managing conditions like dropsy through targeted medicinal use.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Plantaginaceae
- Distribution
- Not available
- Plant Parts
- Leaf · Seed
Classification
Common Names
Digitalis purpurea is a fascinating plant known by a wide variety of regional names across different cultures. In some areas, it is commonly referred to as Almindelig fingerbøl, reflecting its local identity. It also carries the distinct name Arba ditali, adding to its linguistic diversity. Within Welsh traditions, the plant is frequently called Bysedd Cochion or Bysedd Ellyllon. Finally, it is sometimes known as Bysedd y Cŵn, illustrating the many ways this single species is recognized.
Sources: Catalogue of Life (COL)
Taxonomy
Digitalis purpurea belongs to the vast kingdom Plantae, representing the diverse life found within the botanical world. This species is classified under the class Equisetopsida and falls within the specific order Lamiales. Within this taxonomic hierarchy, it is a prominent member of the family Plantaginaceae. The plant is further defined by its placement in the genus Digitalis, which characterizes its unique biological traits. Through these various relationships, scientists can accurately map its position within the complex tree of life.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Lamiales |
| Family | Plantaginaceae |
| Genus | Digitalis |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Digitalis purpurea exhibits a diverse geographical range that spans across several significant regions. This plant is widely distributed throughout Africa, with specific presence noted in Northern Africa and Morocco. Its reach extends into the Macaronesian islands, including the Azores, Madeira, and the Canary Islands. Furthermore, the species can be found in South Tropical Africa, particularly within Malawi. These various locations highlight the plant's ability to thrive across distinct African and Atlantic environments.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Digitalis purpurea is a distinct herb characterized by its sturdy, self-supporting growth form. This plant displays a remarkable range in stature, with heights varying from a diminutive 0.3 m to a maximum of 2.5 m. For many established specimens, a common height of approximately 1.096 m is frequently observed. Such versatility in size allows it to adapt effectively to various environmental conditions. Ultimately, these physical dimensions contribute to the plant's striking presence in the landscape.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Digitalis purpurea is a highly significant medicinal plant primarily valued for its production of bioactive cardiac glycosides. These essential compounds, which are used extensively in the treatment of heart failure, include specific substances such as digitoxin. Beyond these primary therapeutic agents, the plant's chemical profile is further enriched by the presence of various secondary metabolites. Research has specifically identified the phenylethanoid glycosides calceolarioside A and calceolarioside B within its extracts. Understanding these complex chemical relationships is vital for advancing the pharmaceutical applications of the species.
Conditions
Digitalis purpurea demonstrates a diverse range of biological activities, including the ability to treat Corcyra cephalonica and Helicoverpa armigera through its insecticidal properties. In a medical context, the plant has a long history of being used to treat dropsy. Research into its chemical components has also revealed that certain cardenolide glycosides extracted from the plant can treat HL-60 leukemia cells due to their potent cytotoxic activity. Paradoxically, the plant is also associated with foxglove poisoning, a condition that can occur in animals like red deer when they ingest the plant.
Preparations
Digitalis purpurea is prepared as CH2Cl2-MeOH (1:1) extracts to identify phenylethanoid glycosides with PKCalpha-inhibitory activity. This plant is also prepared as a general extract, which has been used in neutrophil multitarget functional bioassays to study inflammatory processes. Historically, the species was prepared as an infusion of digitalis to provide medicinal value for patients suffering from cardiac failure. Additionally, Digitalis purpurea is prepared as shoot cultures to facilitate the purification and characterization of enzymes like progesterone 5 beta-reductase. These various preparation methods allow researchers to isolate specific bioactive compounds and study the plant's complex biochemical properties.
Parts used
Digitalis purpurea is a plant of significant pharmaceutical interest due to the various bioactive compounds found within its different structures. Scientific research frequently focuses on the leaves, where high-performance liquid chromatography is used to quantify essential cardiac glycosides like digitoxin and gitoxin. Beyond the foliage, the seeds of the plant have also proven to be a rich source of chemical diversity. Investigations into these seeds have led to the isolation of several new cardenolide glycosides that exhibit potent cytotoxic activity against cancer cells. Consequently, both the leaves and seeds serve as critical components for understanding the therapeutic potential of this species.